期刊文献+

山海神茵汤治疗非酒精性脂肪肝58例疗效观察 被引量:2

Clinical Observation of Shan-hai Shen-yin Decoction on Nonalcoholic Fatty Liver,A Report of 58 Cases
下载PDF
导出
摘要 目的:探讨山海神茵汤治疗非酒精性脂肪肝病的临床疗效。方法:选择非酒精性脂肪肝患者108例,按就诊顺序,随机分为治疗组58例和对照组50例。治疗组予自拟山海神茵汤治疗,每次口服200mL,2次/d;对照组予水林佳胶囊3粒/次,3次/d。疗程均为12周。结果:治疗组58例,治愈30例,显效23例,无效5例,总有效率91.38%;对照组58例,治愈22例,显效15例,无效13例,总有效率77.59%。两组比效差异具有显著性意义(P(0.05)。两组血清丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)治疗后均有所降低,与治疗前比较差异有显著性意义(P<0.01),说明两组方案均能有效改善肝功能;治疗组在改善血中甘油三酯(TG)、总胆固醇(TC)水平方面不优于对照组(P>0.05)。结论:自拟山海神茵汤可有效治疗非酒精性脂肪肝。 Objective: To observe the clinical curative effect of Shah-hal Shen-yin Decoction on nonalcoholic fatty liver disease. Method: 108 cases with nonalcoholic fatty liver disease were divided into two groups randomly according to visiting sequence. 58 cases in treatment group were treated by Shan- hal Shen - yin Decoction, 200ml once and two times a day. And 50 cases in control group were treated by Shui-lin-jia Capsule, 3 capsules once and 3 times a day. The treatment course included 12 weeks. Result: In treatment group 30 cases were cured, 23 cases were effective, and 5 cases were ineffective. The total effective rate was 91.37%. In control group 22 cases were cured, 15 cases were effective, and 13 cases were ineffective. The total effective rate was 74%. There was significant difference between the two groups ( P 〈 0.05 ). ALT and AST were decreased after treating, and there was also significant difference between before treating and after treating (P 〈0. 01 ). That was to say, the two projects could improve hepatic function, but treatment group was not better than control group on improving TG and TC ( P 〉 0. 05 ). Conclusion : Shan-hai Shen-yin Decoction can heal nonalcoholic fatty liver disease effectively.
作者 姚轶 耿昌海
出处 《山西中医》 2009年第7期12-13,共2页 Shanxi Journal of Traditional Chinese Medicine
关键词 非酒精性脂肪肝 山海神茵汤 中医药疗法 nonalcoholic fatty liver disease,Shah-hal Shen-yin Decoction, TCM therapy
  • 相关文献

参考文献2

二级参考文献13

  • 1范建高 曾民德 等.上海市4009名机关职员脂肪肝流行病学调查[J].中华肝脏病杂志,1998,6(1):17-17.
  • 2Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: Implications for epidemiologic studies. Gastroenterology, 2003, 124:248-250.
  • 3Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease.Gastroenterology, 2002, 123: 1705-1725.
  • 4Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology, 2004, 39: 476-483.
  • 5Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med,2000, 132: 112-117.
  • 6Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol, 2002, 17:1098-1105.
  • 7范建高,曾民德,李继强,沈镭,陈政绩,罗国豪,刘天舒.脂肪肝的危险因素分析[J].中华预防医学杂志,1998,32(3):189-189. 被引量:57
  • 8范建高,曾民德,陈政绩,范竹萍,沈镭,李继强,邱德凯.265例脂肪肝患者病因及其特点分析[J].上海医学,1998,21(2):68-70. 被引量:103
  • 9范建高.中国脂肪肝的研究[J].世界华人消化杂志,2001,9(1):6-10. 被引量:114
  • 10中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊断标准[J].中华肝脏病杂志,2003,11(2):71-71. 被引量:1368

共引文献585

同被引文献41

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部